AwardedSpainGoods
Suministro del principio activo denominado "BLINATUMOMAB 38,5 MCG VIAL POLVO INTRAVENOSA "para el Hospital Universitario de Gran Canaria Dr. Negrín.
- Published
- Published 26 June 2026
Overview
The Hospital Universitario de Gran Canaria Dr. Negrín procured the active pharmaceutical ingredient blinatumomab 38.5 mcg intravenous powder vial. The contract, valued at €115,385, was awarded to AMGEN, S.A. on 6 May 2026 and is now complete.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 26 June 2026
Various medicinal products
Award outcome
- Awarded value
- €115,385
- Award date
- 6 May 2026
- AMGEN, S.A
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
26 June 2026
Contracting authority
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Procuring entityLas Palmas de Gran Canaria, Spain
ID_PLATAFORMA: 21050930148853
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.